OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+20.47%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$239M
AUM Growth
+$239M
(+18%)
Cap. Flow
+$7.57M
Cap. Flow
% of AUM
3.16%
Top 10 Holdings %
Top 10 Hldgs %
37.89%
Holding
60
New
11
Increased
16
Reduced
16
Closed
7
Top Buys
| 1 |
RLYP
RELYPSA INC COM
RLYP
|
$6.24M |
| 2 |
Assertio
ASRT
|
$5.44M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$4.66M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$3.82M |
| 5 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$3.78M |
Top Sells
| 1 |
CMRX
Chimerix, Inc.
CMRX
|
$11.8M |
| 2 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$6.24M |
| 3 |
CEMP
Cempra, Inc.
CEMP
|
$4.98M |
| 4 |
Neurocrine Biosciences
NBIX
|
$3.96M |
| 5 |
Tonix Pharmaceuticals
TNXP
|
$3.02M |
Sector Composition
| 1 | Healthcare | 79.19% |